Cited by 74Treatment of Major DepressionDementia and Cognitive Impairment ResearchMental Health Treatment and Access

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Do continued antidepressants protect against dementia in patients with severe depressive disorder?

Kessing, Lars Vedel, Forman, Julie Lyng, Andersen, Per Kragh·2011·International Clinical Psychopharmacology

Abstract

Studies on humans show that depressive disorder is associated with an increased risk of developing cognitive dysfunction, and animal studies suggest that antidepressants may have neuroprotective abilities. On the basis of these observations, it was hypothesized that treatment with antidepressants may decrease the risk of developing dementia in patients with depression. We investigated whether continued treatment with antidepressants is associated with a decreased rate of dementia in a population of patients discharged from psychiatric healthcare service with a diagnosis of depression. We used register data on all prescribed antidepressants in all patients discharged from psychiatric healthcare service with a diagnosis of depression and with subsequent diagnoses of dementia in Denmark from 1995 to 2005. A total of 37 658 patients with a diagnosis of depression at their first psychiatric contact and who were exposed to antidepressants after discharge were included in the study. A total of 2007 patients (5.3%) were subsequently diagnosed with dementia of any kind. The rate of dementia decreased during periods of two or more prescriptions of older antidepressants compared with the period of only one prescription of older antidepressants [relative risk (RR)=0.83 (95% confidence interval (CI)=0.70-0.98)]. This finding was replicated with Alzheimer's disease as the outcome [RR=0.66 (95% CI=0.47-0.94)] but not with dementia of other kinds as the outcome [RR=0.88 (95% CI=0.73-1.06)].…

Overview

Integrity signals

Registry

Crossref · 10.1097/yic.0b013e32834ace0f

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

  • Antidepressants and dementia

    Kessing, L. V., Søndergård, L., Forman, J. L., & Andersen, P. K. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.020 · Cited by 113 · cited 14×

    “, 2008) and antidepressants and dementia (Kessing et al., 2009), used the same kind of analyses.”
    BackgroundResultInfluentialSelf-citation

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Kessing, L. V., Forman, J. L., & Andersen, P. K.
Affiliations
  • Copenhagen University Hospital (DK)
  • University of Copenhagen (DK)
Corresponding author
Kessing, Lars Vedel
Venue
International Clinical Psychopharmacology
Published
2011-11
Volume
26
Issue
6
Pages
316-322
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2085892085
Cited by
74
References
1
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 9 · 2013: 2 · 2012: 5
FWCI
3.58
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
antidepressants, dementia, long-term antidepressant treatment, Alzheimer's disease, selective serotonin reuptake inhibitors, neuroprotection, cognitive impairment, psychiatric hospital discharge
MeSH terms
Aged, Alzheimer Disease, Antidepressive Agents, Dementia, Denmark, Depressive Disorder, Female, Hospitals, Humans, Inpatients, Male, Middle Aged, Outpatients, Registries, Risk, Comorbidity, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Disease Progression, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review